← Leaderboards
Florian Karreth
H. Lee Moffitt Cancer Ctr & Res Inst
$4,692,414
Attributed
$4,692,414
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $963.8K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,692,414 · 7
By mechanism
R01$2,273,687 · 1
R21$1,714,695 · 4
K22$532,032 · 1
R03$172,000 · 1
Top collaborators
No co-investigators on record.
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Noemi Andor$3,764,187
- Ariosto S Siqueira Silva$1,904,085
- Mehdi Damaghi$4,059,891
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaIn VivoTumorMalignant NeoplasmsIn VitroMouse ModelMelanoma CellOncogenicExperimental StudyMediatingMolecularBiologySeriesGenetic TranscriptionGenesMutantPositioning AttributeRegulationProteinsBiologicalMelanomagenesisMutationOverexpressionMessenger Rna
Grant awards (18)
Exploring anti-sense RNAs in melanocyte transformation and melanoma formation$433,256
R21 · FY2025 · CA · contact PI
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis$416,938
R01 · FY2025 · CA · contact PI
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis$113,616
R01 · FY2025 · CA · contact PI
Targeting a PHGDH metabolic vulnerability in melanoma$433,256
R21 · FY2024 · CA · contact PI
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis$396,092
R01 · FY2024 · CA · contact PI
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis$112,908
R01 · FY2024 · CA · contact PI
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis$408,600
R01 · FY2023 · CA · contact PI
Characterization of the oncogenic potential of circRNAs in melanoma$192,997
R21 · FY2023 · CA · contact PI
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis$408,595
R01 · FY2022 · CA · contact PI
Characterization of the oncogenic potential of circRNAs in melanoma$236,321
R21 · FY2022 · CA · contact PI
Exploring miR-29 in melanoma progression and prevention$226,372
R21 · FY2022 · CA · contact PI
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis$416,938
R01 · FY2021 · CA · contact PI
Exploring miR-29 in melanoma progression and prevention$192,493
R21 · FY2021 · CA · contact PI
An ESC-GEMM platform for rapid melanoma mouse modeling$86,000
R03 · FY2019 · CA · contact PI
BACH2 in Melanoma Development and Resistance$177,344
K22 · FY2018 · CA · contact PI
An ESC-GEMM platform for rapid melanoma mouse modeling$86,000
R03 · FY2018 · CA · contact PI
BACH2 in Melanoma Development and Resistance$177,344
K22 · FY2017 · CA · contact PI
BACH2 in Melanoma Development and Resistance$177,344
K22 · FY2016 · CA · contact PI